Efficacy and Safety of Combination Eribulin + Pembrolizumab
Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Womens Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School elaborates on the ef...
Author: obr
Added: 07/02/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts